Sédation et analgésie du cheval pour l’immobilisation avant transport et prise en charge à domicile lors d’une fracture de phalange (notice n° 1639713)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04026cam a2200385 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260201062242.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gavet, Morgane |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Sédation et analgésie du cheval pour l’immobilisation avant transport et prise en charge à domicile lors d’une fracture de phalange |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 25 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Lors d’une suspicion de fracture phalangienne chez le cheval, la qualité de la sédation-analgésie est essentielle pour assurer la sécurité des intervenants, le confort de l’animal, et permettre l’évaluation clinique ainsi que la stabilisation du membre avant tout transport. Cet article propose une approche raisonnée du choix des molécules sédatives et analgésiques disponibles chez le cheval, en tenant compte de leur potentiel thérapeutique, de leurs effets indésirables et des considérations légales. Le transport ne doit être envisagé qu’après contrôle de la douleur et une immobilisation adéquate du membre atteint. Les alpha-2-agonistes sont les sédatifs de choix, à associer à des opioïdes pour l’analgésie et une synergie des effets sédatifs. L’administration d’anti-inflammatoires non-stéroïdiens (AINS) est recommandée si le cheval est hémodynamiquement stable. Des adjuvants comme la kétamine ou l’acépromazine peuvent compléter le protocole selon les besoins. À domicile, l’analgésie à long terme doit être individualisée. Elle repose principalement sur les AINS, dont le choix et le suivi visent à éviter les effets indésirables et à optimiser l’analgésie. Des recommandations pratiques de surveillance lors d’administration prolongée d’AINS sont proposées. Certains adjuvants peuvent également être ajoutés à domicile. Cette démarche vise à améliorer la prise en charge globale des chevaux traités de manière conservatrice pour une fracture de phalange. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | In case of suspected phalangeal fracture in horses, appropriate sedation and analgesia are essential to ensure the safety of handlers, the comfort of the animal, and to allow clinical evaluation and limb stabilisation before any transport. This article proposes a rational approach to the selection of available sedative and analgesic drugs, taking into account their efficacy, side effects, and legal considerations. Transport should only be considered once pain is controlled and the limb is adequately immobilized. Alpha-2 agonists are the sedatives of choice and should be combined with opioids to provide analgesia and synergistic sedative effects. The administration of non-steroidal anti-inflammatory drugs (NSAIDs) is recommended once the horse is hemodynamically stable. Additional substances such as ketamine or acepromazine may be added to the protocol as needed. At home, long-term analgesia must be individualized. It relies mainly on NSAIDs, selected to optimise analgesia while minimising adverse effects thanks to adequate monitoring. Practical recommendations for toxicity monitoring during long term NSAIDs administration are provided. Additional substances may be included on a case-by-case basis. This approach aims to improve the overall management of horses treated conservatively for a phalangeal fracture. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adjuvants |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | AINS |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | alpha-2-agonistes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | analgésie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | fracture |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | législation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | opioïdes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | sédation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adjuncts |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | alpha-2-agonists |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | analgesia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | fracture |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | legislation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | NSAIDS |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | opioids |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | sedation |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Debuigne, Morgane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Junot, Stéphane |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Le Nouveau Praticien Vétérinaire - Équine | 18-19 | 1-2 | 2025-11-06 | p. 20-27 | 1767-5081 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-le-nouveau-praticien-veterinaire-equine-2025-1-2-page-20?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-le-nouveau-praticien-veterinaire-equine-2025-1-2-page-20?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux